GLUE
NASD Monte Rosa Therapeutics, Inc.$10.28 ↓ -0.04 (-0.39%) Trading Down from the previous close of $10.32
- YTD change
- -34.44%
- vs 20-day SMA
- -13.01%
- vs 200-day SMA
- -43.09%
Price ranges
Price & Performance
-7.73 (-42.83%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 77.4% away from all-time highs of $45.56
- GLUE is down 34% since the beginning of the year
- GLUE is up 22% over the past 12 months
- GLUE is down 28% over the past 1 month
- 24% of all GLUE investors are betting against GLUE
GLUE reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +22.0%.
- Previous minute
- +$0.00
- Last hour
- -$0.14
- Last 5 days
- -8.70%
- vs 8-day SMA
- -4.44%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.